Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams.

After Ms Cheryl Tan displayed the first signs of a debilitating neurological condition at age 23, daily tasks such as taking ...

Frances Flemming gave her brain to science after choosing voluntary assisted dying. Donations such as hers are crucial to ...

At one point during her health journey, Chandler resident Erin Kienlen thought she had amyotrophic lateral sclerosis, or ALS.

According to the National MS Society, nearly one million people are living with MS in the U.S. The annual Walk MS event has been going on for decades in Savannah, and people who have been coming out ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

Maria Lowe, Pharm.D., BCPS, associate vice president of pharmaceutical intelligence at the Institute for Clinical and ...